fda compounding semaglutide enforcement november 2025 September 15, 2025: Telehealth company must stop implying its compounded GLP-1 is FDA-approved, warns – Partnership for Safe Medicines End of Semaglutide Shortage Means

At the 12 mg dose at 48 weeks: -24.2% mean body weight versus -2.1% placebo

So far, more than 3,800 individual lawsuits have been consolidated in a federal MDL in Pennsylvania, but MDLs and class action lawsuits are very different

Combining them can cause significant GI slowing, constipation, and in some cases, delayed absorption of other medications taken at the same time

Multi-indication label expansion: Semaglutide approved across obesity, cardiovascular risk reduction, MASH, and sleep apnea creates a total addressable patient population of approximately 640 million globally nearly four times the obesity-only base adding new prescriber populations including cardiologists, hepatologists, and sleep medicine specialists

Batch numbers should match product labels exactly